author-photo

Eric Luedke

Ohio State University

14

Papers

221

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Bortezomib and interferon alpha-2b in metastatic melanoma.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)
IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.

2017 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (30)
MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions

2017 Cancer immunology research
Show All
- Source
- Cite
- Save
Citations (12)
The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma

2016 Oncotarget
Show All
- Source
- Cite
- Save
Citations (5)
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease.

2015 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (74)
A phase I trial of bortezomib and interferon-α-2b in metastatic melanoma.

2014 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (10)
Monoclonal antibody therapy of pancreatic cancer with cetuximab: potential for immune modulation.

2012 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (24)
Cetuximab therapy in head and neck cancer: Immune modulation with interleukin-12 and other natural killer cell–activating cytokines

2012 Surgery
Show All
- Source
- Cite
- Save
Citations (48)